Back to Search
MARISA BRIZZI, PHARMD
PHARMD
Pharmacotherapy Pharmacist
NPI: 1407352073Individual
Specialties, Licenses & Credentials
Pharmacotherapy PharmacistPrimary
Pharmacist — Pharmacotherapy
Code: 1835P1200X
051.300396(IL)
Research & Publications (20)
Negative regulation of beta4 integrin transcription by homeodomain-interacting protein kinase 2 and p53 impairs tumor progression.
PMID 19567674·Cancer Res·2009
8-other
Activity and safety of a prolonged daily schedule of zoledronic acid in a patient with bone metastases from urothelial carcinoma.
PMID 19153111·Ann Oncol·2009
5-case
Formation of STAT5/PPARgamma transcriptional complex modulates angiogenic cell bioavailability in diabetes.
PMID 18927468·Arterioscler Thromb Vasc Biol·2009
7-preclinical
Phosphorylated ERalpha, HIF-1alpha, and MAPK signaling as predictors of primary endocrine treatment response and resistance in patients with breast cancer.
PMID 19064988·J Clin Oncol·2009
3-trial
Endothelial progenitor cells and their potential clinical implication in cardiovascular disorders.
PMID 19636208·J Endocrinol Invest·2009
6-review
Inhibition of CD203c membrane up-regulation in human basophils by high dilutions of histamine: a controlled replication study.
PMID 19418203·Inflamm Res·2009
8-other
Immunomodulation of FOXP3+ regulatory T cells by the aromatase inhibitor letrozole in breast cancer patients.
PMID 19188178·Clin Cancer Res·2009
8-other
Presurgical systemic treatment of nonmetastatic breast cancer: facts and open questions.
PMID 18997125·Oncologist·2008
6-review
Primary aldosteronism (PA) and endothelial progenitor cell (EPC) bioavailability.
PMID 18410543·Clin Endocrinol (Oxf)·2008
8-other
Down-regulation of phosphatidylinositol 3'-kinase/AKT/molecular target of rapamycin metabolic pathway by primary letrozole-based therapy in human breast cancer.
PMID 18451231·Clin Cancer Res·2008
2-rct
Interleukin-3 promotes expansion of hemopoietic-derived CD45+ angiogenic cells and their arterial commitment via STAT5 activation.
PMID 18460645·Blood·2008
7-preclinical
Oxidative stress-mediated mesangial cell proliferation requires RAC-1/reactive oxygen species production and beta4 integrin expression.
PMID 17604276·J Biol Chem·2007
8-other
Somatostatin receptor type 2A immunohistochemistry in neuroendocrine tumors: a proposal of scoring system correlated with somatostatin receptor scintigraphy.
PMID 17873898·Mod Pathol·2007
4-observational
Six-year stabilisation of a relapsed pelvic mass from rectal cancer after oxaliplatin-containing chemotherapy.
PMID 17551754·J Cancer Res Clin Oncol·2007
5-case
The role of variability in evaluating ultra high dilution effects: considerations based on plant model experiments.
PMID 17971672·Forsch Komplementmed·2007
8-other
Regulation of hepatocyte growth factor activator inhibitor 2 by hypoxia in breast cancer.
PMID 17255277·Clin Cancer Res·2007
2-rct
C-KIT, by interacting with the membrane-bound ligand, recruits endothelial progenitor cells to inflamed endothelium.
PMID 17289809·Blood·2007
7-preclinical
VEGFR-1 (FLT-1), beta1 integrin, and hERG K+ channel for a macromolecular signaling complex in acute myeloid leukemia: role in cell migration and clinical outcome.
PMID 17420287·Blood·2007
8-other
Hypoxia-inducible factor-1alpha expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer.
PMID 16899602·Clin Cancer Res·2006
2-rct
Role of carbonic anhydrase IX expression in prediction of the efficacy and outcome of primary epirubicin/tamoxifen therapy for breast cancer.
PMID 16954440·Endocr Relat Cancer·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1740 W TAYLOR ST
CHICAGO, IL 60612 - Phone
- (727) 458-0007
Quick Facts
- NPI
- 1407352073
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile